Analystreport

CymaBay Therapeutics Inc (NASDAQ: CBAY) was upgraded by analysts at Oppenheimer Holdings Inc. to a "buy" rating. They now have a $4.00 price target on the stock.

CymaBay Therapeutics Inc.  (CBAY) 
Last cymabay therapeutics inc. earnings: 3/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cymabay.com